iCAD, Inc. (NASDAQ: ICAD) $79M (MarketCap) Secures Contract with Veterans Administration and Department of Defense Hospitals

iCad, Inc. is an industry-leading provider oftreatment facilities worldwide will now have
advanced image analysis and workflow solutionsaccess to CAD solutions for their mammography
for the early identification of cancer. It offers asystems following this agreement. This CAD
comprehensive range of high-performance,technology uses advanced algorithms to evaluate
upgradeable Computer-Aided Detection systemsvarious aspects of the image data, assisting
and workflow solutions for mammography,radiologists in detecting cancer by providing a
Magnetic Resonance Imaging (MRI) and Computedvisual indication of suspicious areas. The American
Tomography (CT). The company received FDACancer Society outlines recommendations for the
approval for its first breast cancer detectionearly detection of breast cancer, including
product in 2002, and more than 3,500 iCadrecommended yearly mammograms starting at
systems have been placed in healthcare practicesage 40.
worldwide since. iCAD's solutions aid in the early 
detection of the most prevalent cancers including 
breast and prostate, and in the future colon and"iCAD is pleased to be able to offer advanced
lung cancer.computer-aided detection technology, a potentially
The company is currently trading at 1.74, up .09life-saving tool, to U.S. military veterans," said Ken
or 5.45%. Today, iCAD announced that it hasFerry, President and CEO of iCAD. "We hope that
signed an agreement with the Defense Supplyby adding CAD, the VA and Department of
Center to provide federal healthcare facilitiesDefense Hospitals will be able to identify breast
including Veteran's Administration (VA) andcancer at an earlier stage among the women who
Department of Defense Hospitals withs itshave served or who are currently serving in our
Computer-Aided-Detection (CAD) technology forarmed forces.
mammography. Over 400 federal medical